HKU Scholars Hub: Browsing DSpace

Browsing by Author Choo, SP

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 2 to 9 of 9 < previous

	Title	Author(s)	Issue Date	Views
	Efficacy and tolerability of Sorafenib, Capecitabine and Oxaliplatin (Secox) in patients with advanced hepatocellular carcinoma: a multi-centre phase II study (Abstract) Proceeding/Conference:International Meeting Hepatocellular Carcinoma, IMHCC 2011	Yau, TCC Chan, P Cheung, FY Lee, AS Yau, TK Choo, SP Toh, HC Leung, AK Wong, JS Wong, S Lau, J Pang, RWC Fan, ST Poon, RTP	2011	110
	First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma Journal:Cancer Discovery	Kim, RD Sarker, D Meyer, T Yau, T Macarulla, T Park, JW Choo, SP Hollebecque, A Sung, MW Lim, HY Mazzaferro, V Trojan, J Zhu, AX Yoon, JH Sharma, S Lin, ZZ Chan, SL Faivre, S Feun, LG Yen, C-J Dufour, J-F Palmer, DH Llovet, JM Manoogian, M Tugnait, M Stransky, N Hagel, M Kohl, NE Lengauer, C Sherwin, CA Schmidt-Kittler, O Hoeflich, KP Shi, H Wolf, BB Kang, Y-K	2019	96
	A multicenter phase II study of sorafenib, capecitabine, and oxaliplatin (SECOX) in patients with advanced hepatocellular carcinoma: final results of Hong Kong-Singapore Hepatocellular Carcinoma Research Collaborative Group study Proceeding/Conference:Journal of Clinical Oncology	Yau, TCC Cheung, FY Lee, F Choo, SP Wong, HYH Toh, HC Leung, AK Chan, P Yau, TK Wong, J Tang, YF Lau, JSM Cheung, TT Fan, ST Poon, RTP	2013	210
	Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial Journal:Lancet	El-Khoueiry, AB Sangro, B Yau, TCC Crocenzi, TS Kudo, M Hsu, C Kim, TY Choo, SP Trojan, J Welling, TH Meyer, T Kang, YK Yeo, W Chopra, A Anderson, J Dela Cruz, C Lang, L Neely, J Tang, H Dastani, HB Melero, I	2017	151
	Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma Journal:Clinical Cancer Research	Lim, HY Merle, P Weiss, KH Yau, TCC Ross, P Mazzaferro, V Blanc, JF Ma, YT Yen, CJ Kocsis, J Choo, SP Sukeepaisarnjaroen, W Gérolami, R Dufour, JF Gane, EJ Ryoo, BY Peck-Radosavljevic, M Dao, T Yeo, W Lamlertthon, W Thongsawat, S Teufel, M Roth, K Reis, D Childs, BH Krissel, H Llovet, JM	2018	50
	A phase II trial of ixabepilone in Asian patients with advanced gastric cancer previously treated with fluoropyrimidine-based chemotherapy Journal:Cancer Chemotherapy and Pharmacology	Kim, YH Muro, K Yasui, H Chen, JS Ryu, MH Park, SH Chu, KM Choo, SP Sanchez, T DelaCruz, C Mukhopadhyay, P Lainas, I Li, CP	2012	64
	Phase II trial of sorafenib with capecitabine and oxaliplatin (SECOX) in patients with locally advanced or metastatic hepatocellular carcinoma Proceeding/Conference:European Journal of Cancer Supplements	Yau, TCC Chan, P Cheung, FY Lee, AS Yau, TK Choo, SP Lau, J Wong, JS Fan, ST Poon, RTP	2009	95
	Safety and Antitumor Activity of Nivolumab (Nivo) in Patients (pts) with Advanced Hepatocellular Carcinoma (HCC): Interim Analysis of Dose-Expansion Cohorts from the Phase 1/2 CheckMate-040 Study Proceeding/Conference:Liver Cancer	Sangro, B Melero, I Yau, TCC Hsu, C Kudo, M Crocenzi, TS Kim, TY Choo, SP Trojan, J Meyer, T Kang, YK Anderson, J dela Cruz, C Lang, L Neely, J El-Khoueiry, AB	2016	151

Showing results 2 to 9 of 9 < previous